Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


Articles published in Arch Virol

Retrieve available abstracts of 15 articles:
HTML format



Single Articles


    November 2022
  1. GRACHEVA AV, Korchevaya ER, Ammour YI, Smirnova DI, et al
    Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet light.
    Arch Virol. 2022;167:2181-2191.
    PubMed     Abstract available


    September 2022
  2. LI ZX, Feng S, Zhang H, Zhuang XY, et al
    Immunogenicity and protective efficacy of a DNA vaccine inducing optimal expression of the SARS-CoV-2 S gene in hACE2 mice.
    Arch Virol. 2022 Sep 9. pii: 10.1007/s00705-022-05562.
    PubMed     Abstract available


  3. PONNUSAMY P, Sukumar K, Raja A, Saravanan S, et al
    Characterization of infectious laryngotracheitis virus isolates from laying hens during 2019-2020 outbreaks in Tamil Nadu, India.
    Arch Virol. 2022;167:1819-1829.
    PubMed     Abstract available


    July 2022
  4. JUNG JS, Lee R, Yoon SI, Lee GS, et al
    Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea.
    Arch Virol. 2022 Jul 11. pii: 10.1007/s00705-022-05519.
    PubMed     Abstract available


  5. DOAN HTT, Do RT, Thao PTP, Le XTK, et al
    Molecular genotypic analysis of porcine circovirus type 2 reveals the predominance of PCV2d in Vietnam (2018-2020) and the association between PCV2h, the recombinant forms, and Vietnamese vaccines.
    Arch Virol. 2022 Jul 6. pii: 10.1007/s00705-022-05517.
    PubMed     Abstract available


    June 2022
  6. BHANUPRAKASH V, Hosamani M, Venkatesan G, Singh RK, et al
    Long-term protective immunity to goatpox in goats after a single immunization with a live attenuated goatpox vaccine.
    Arch Virol. 2022 Jun 26. pii: 10.1007/s00705-022-05505.
    PubMed     Abstract available


  7. DAHER-NASHIF S, Al-Anany R, Ali M, Erradi K, et al
    COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.
    Arch Virol. 2022 Jun 20. pii: 10.1007/s00705-022-05495.
    PubMed     Abstract available


    May 2022
  8. PIERI M, Nicolai E, Nuccetelli M, Sarubbi S, et al
    Validation of a quantitative lateral flow immunoassay (LFIA)-based point-of-care (POC) rapid test for SARS-CoV-2 neutralizing antibodies.
    Arch Virol. 2022;167:1285-1291.
    PubMed     Abstract available


    April 2022
  9. BIN UMAIR M, Akusa FN, Kashif H, Seerat-E-Fatima, et al
    Viruses as tools in gene therapy, vaccine development, and cancer treatment.
    Arch Virol. 2022 Apr 24. pii: 10.1007/s00705-022-05432.
    PubMed     Abstract available


    February 2022
  10. OZ ME, Torlak E
    A high-resolution melting assay to differentiate a peste des petits ruminants virus vaccine strain from field isolates in Turkey.
    Arch Virol. 2022 Feb 11. pii: 10.1007/s00705-022-05386.
    PubMed     Abstract available


  11. ZHOU J, Li C, Tang A, Li H, et al
    Immunogenicity of an inactivated novel goose parvovirus vaccine for short beak and dwarfism syndrome in Cherry Valley ducks.
    Arch Virol. 2022 Feb 11. pii: 10.1007/s00705-021-05352.
    PubMed     Abstract available


  12. LI H, Ge Z, Luo Q, Fu Q, et al
    A highly pathogenic Marek's disease virus isolate from chickens immunized with a bivalent vaccine in China.
    Arch Virol. 2022 Feb 7. pii: 10.1007/s00705-021-05355.
    PubMed     Abstract available


    January 2022
  13. COKCALISKAN C, Tuncer-Goktuna P, Sareyyupoglu B, Turkoglu T, et al
    Booster administration can make a difference in the antibody response to intradermal foot-and-mouth disease vaccination in cattle.
    Arch Virol. 2022 Jan 16. pii: 10.1007/s00705-021-05273.
    PubMed     Abstract available


    December 2021
  14. ZHAO W, Zhang P, Bai S, Lv M, et al
    Heterologous prime-boost regimens with HAdV-5 and NDV vectors elicit stronger immune responses to Ebola virus than homologous regimens in mice.
    Arch Virol. 2021;166:3333-3341.
    PubMed     Abstract available


    October 2021
  15. JANG Y, Seo SH
    H5 cleavage-site peptide vaccine protects chickens from lethal infection by highly pathogenic H5 avian influenza viruses.
    Arch Virol. 2021 Oct 25. pii: 10.1007/s00705-021-05284.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: